Logo image of NUVA.DE

NORATIS AG (NUVA.DE) Stock Fundamental Analysis

FRA:NUVA - Deutsche Boerse Ag - DE000A2E4MK4 - Common Stock - Currency: EUR

0.75  -0.03 (-3.23%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NUVA. NUVA was compared to 70 industry peers in the Real Estate Management & Development industry. NUVA has a bad profitability rating. Also its financial health evaluation is rather negative. NUVA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NUVA had negative earnings in the past year.
NUVA had a positive operating cash flow in the past year.
NUVA had positive earnings in 4 of the past 5 years.
NUVA had negative operating cash flow in 4 of the past 5 years.
NUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFNUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

NUVA's Return On Assets of -6.08% is on the low side compared to the rest of the industry. NUVA is outperformed by 68.12% of its industry peers.
NUVA has a worse Return On Equity (-42.03%) than 76.81% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.00%, NUVA is in line with its industry, outperforming 56.52% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NUVA is in line with the industry average of 4.48%.
Industry RankSector Rank
ROA -6.08%
ROE -42.03%
ROIC 1%
ROA(3y)0.49%
ROA(5y)1.08%
ROE(3y)2.81%
ROE(5y)5.59%
ROIC(3y)2.51%
ROIC(5y)2.76%
NUVA.DE Yearly ROA, ROE, ROICNUVA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

1.3 Margins

NUVA has a Operating Margin of 12.12%. This is in the better half of the industry: NUVA outperforms 62.32% of its industry peers.
In the last couple of years the Operating Margin of NUVA has declined.
NUVA has a Gross Margin of 33.21%. This is comparable to the rest of the industry: NUVA outperforms 49.28% of its industry peers.
In the last couple of years the Gross Margin of NUVA has declined.
Industry RankSector Rank
OM 12.12%
PM (TTM) N/A
GM 33.21%
OM growth 3Y-12.49%
OM growth 5Y-25.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.23%
GM growth 5Y-19.43%
NUVA.DE Yearly Profit, Operating, Gross MarginsNUVA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUVA is destroying value.
Compared to 1 year ago, NUVA has more shares outstanding
The number of shares outstanding for NUVA has been increased compared to 5 years ago.
Compared to 1 year ago, NUVA has about the same debt to assets ratio.
NUVA.DE Yearly Shares OutstandingNUVA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
NUVA.DE Yearly Total Debt VS Total AssetsNUVA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 1.34, we must say that NUVA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.34, NUVA is in the better half of the industry, outperforming 71.01% of the companies in the same industry.
NUVA has a debt to FCF ratio of 25.77. This is a negative value and a sign of low solvency as NUVA would need 25.77 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 25.77, NUVA is in line with its industry, outperforming 55.07% of the companies in the same industry.
NUVA has a Debt/Equity ratio of 5.06. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 5.06, NUVA is not doing good in the industry: 81.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.06
Debt/FCF 25.77
Altman-Z 1.34
ROIC/WACC0.31
WACC3.22%
NUVA.DE Yearly LT Debt VS Equity VS FCFNUVA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 7.75 indicates that NUVA has no problem at all paying its short term obligations.
The Current ratio of NUVA (7.75) is better than 94.20% of its industry peers.
NUVA has a Quick Ratio of 7.75. This is a bad value and indicates that NUVA is not financially healthy enough and could expect problems in meeting its short term obligations.
NUVA has a Quick ratio of 0.34. This is in the lower half of the industry: NUVA underperforms 68.12% of its industry peers.
Industry RankSector Rank
Current Ratio 7.75
Quick Ratio 0.34
NUVA.DE Yearly Current Assets VS Current LiabilitesNUVA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for NUVA have decreased strongly by -628.53% in the last year.
The Revenue has decreased by -6.90% in the past year.
Measured over the past years, NUVA shows a small growth in Revenue. The Revenue has been growing by 1.41% on average per year.
EPS 1Y (TTM)-628.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-321.33%
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y27.99%
Revenue growth 5Y1.41%
Sales Q2Q%-38.01%

3.2 Future

Based on estimates for the next years, NUVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.58% on average per year.
Based on estimates for the next years, NUVA will show a quite strong growth in Revenue. The Revenue will grow by 13.83% on average per year.
EPS Next Y-154.43%
EPS Next 2Y26.68%
EPS Next 3Y24.72%
EPS Next 5Y16.58%
Revenue Next Year-2.16%
Revenue Next 2Y37.08%
Revenue Next 3Y30.59%
Revenue Next 5Y13.83%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NUVA.DE Yearly Revenue VS EstimatesNUVA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
NUVA.DE Yearly EPS VS EstimatesNUVA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4

2

4. Valuation

4.1 Price/Earnings Ratio

NUVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NUVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUVA.DE Price Earnings VS Forward Price EarningsNUVA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

NUVA's Enterprise Value to EBITDA ratio is in line with the industry average.
NUVA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NUVA is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.69
EV/EBITDA 60.38
NUVA.DE Per share dataNUVA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as NUVA's earnings are expected to grow with 24.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.68%
EPS Next 3Y24.72%

0

5. Dividend

5.1 Amount

No dividends for NUVA!.
Industry RankSector Rank
Dividend Yield N/A

NORATIS AG

FRA:NUVA (5/22/2025, 7:00:00 PM)

0.75

-0.03 (-3.23%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-25 2025-05-25/amc
Earnings (Next)09-29 2025-09-29
Inst Owners0.58%
Inst Owner ChangeN/A
Ins Owners2.11%
Ins Owner ChangeN/A
Market Cap10.18M
Analysts40
Price Target1.09 (45.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-30.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF 0.69
P/OCF 0.69
P/B 0.16
P/tB 0.16
EV/EBITDA 60.38
EPS(TTM)-4.25
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)1.09
FCFY145.76%
OCF(TTM)1.09
OCFY145.91%
SpS3.5
BVpS4.82
TBVpS4.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.08%
ROE -42.03%
ROCE 1.45%
ROIC 1%
ROICexc 1.03%
ROICexgc 1.03%
OM 12.12%
PM (TTM) N/A
GM 33.21%
FCFM 31.26%
ROA(3y)0.49%
ROA(5y)1.08%
ROE(3y)2.81%
ROE(5y)5.59%
ROIC(3y)2.51%
ROIC(5y)2.76%
ROICexc(3y)2.58%
ROICexc(5y)2.87%
ROICexgc(3y)2.58%
ROICexgc(5y)2.87%
ROCE(3y)3.63%
ROCE(5y)4%
ROICexcg growth 3Y3.42%
ROICexcg growth 5Y-34.46%
ROICexc growth 3Y3.42%
ROICexc growth 5Y-34.46%
OM growth 3Y-12.49%
OM growth 5Y-25.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.23%
GM growth 5Y-19.43%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 5.06
Debt/FCF 25.77
Debt/EBITDA 52.51
Cap/Depr 2.76%
Cap/Sales 0.03%
Interest Coverage 0.31
Cash Conversion 235.94%
Profit Quality N/A
Current Ratio 7.75
Quick Ratio 0.34
Altman-Z 1.34
F-Score3
WACC3.22%
ROIC/WACC0.31
Cap/Depr(3y)21.85%
Cap/Depr(5y)22.27%
Cap/Sales(3y)0.13%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-628.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-321.33%
EPS Next Y-154.43%
EPS Next 2Y26.68%
EPS Next 3Y24.72%
EPS Next 5Y16.58%
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y27.99%
Revenue growth 5Y1.41%
Sales Q2Q%-38.01%
Revenue Next Year-2.16%
Revenue Next 2Y37.08%
Revenue Next 3Y30.59%
Revenue Next 5Y13.83%
EBIT growth 1Y-39.66%
EBIT growth 3Y12.01%
EBIT growth 5Y-24.3%
EBIT Next Year-79.85%
EBIT Next 3Y25.36%
EBIT Next 5Y23.98%
FCF growth 1Y134.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.74%
OCF growth 3YN/A
OCF growth 5YN/A